Literature DB >> 32968873

Phosphorylation at S548 as a Functional Switch of Sterile Alpha and TIR Motif-Containing 1 in Cerebral Ischemia/Reperfusion Injury in Rats.

Tao Xue1, Qing Sun1, Yijie Zhang1, Xin Wu1, Haitao Shen1, Xiang Li1, Jiang Wu1, Haiying Li2, Zhong Wang3, Gang Chen1.   

Abstract

Sterile alpha and Toll/interleukin-1 receptor motif-containing 1 (SARM1) is a pro-degenerative molecule in Wallerian degeneration, which is mainly expressed in brain/neurons and colocalized with mitochondria and microtubules. The aim of this study was to determine the role of SARM1 in cerebral ischemia/reperfusion (I/R) injury and the underlying mechanisms. In vivo, a middle cerebral artery occlusion/reperfusion (MCAO/R) model in adult male Sprague Dawley rats (250-300 g) was established, and in vitro, cultured primary neurons were subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) to imitate I/R injury. Overexpression lentiviruses encoding wild-type SARM1 and SARM1 with serine 548 alanine mutation (S548A) were constructed and administered to rats by intra-penumbral injection. First, the potential role of SARM1 in cerebral I/R injury was confirmed by the increased protein levels of SARM1 within penumbra tissue, especially in neurons. Second, there was an increase in the phosphorylation ratio of p-SARM1(S548)/SARM1 at 2 h after MCAO/R. Third, on the basis of site-specific mutagenesis, we identified S548 as a key site for SARM1 phosphorylation in I/R conditions. Fourth, SARM1 (S548A) overexpression reduced infarct size, neuronal death, and neurobehavioral dysfunction, while wild-type SARM1 overexpression had the opposite effects. Finally, we found that SARM1 phosphorylation at the S548 site switched SARM1 function from promoting mitochondrial transport to inhibiting mitochondrial transport along axons after I/R injury. Restriction of SARM1 phosphorylation at S548 may be a promising intervention target for I/R injury; thus, exogenous administration of SARM1 (S548A) may be a novel strategy for improving neurological outcomes.

Entities:  

Keywords:  I/R injury; Mitochondrial transport; Neurological outcomes; S548A; SARM1

Year:  2020        PMID: 32968873     DOI: 10.1007/s12035-020-02132-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  62 in total

1.  Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats.

Authors:  J Aronowski; R Strong; J C Grotta
Journal:  J Cereb Blood Flow Metab       Date:  1997-10       Impact factor: 6.200

2.  Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion in the rat pup.

Authors:  S Ashwal; B Tone; H R Tian; D J Cole; B H Liwnicz; W J Pearce
Journal:  Pediatr Res       Date:  1999-10       Impact factor: 3.756

3.  Role of early partial recanalization and intravenous thrombolysis for acute ischemic stroke.

Authors:  Luis Moscote-Salazar
Journal:  J Clin Neurosci       Date:  2018-04-06       Impact factor: 1.961

4.  Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia.

Authors:  Pei Wang; Yun-Feng Guan; Hui Du; Qi-Wei Zhai; Ding-Feng Su; Chao-Yu Miao
Journal:  Autophagy       Date:  2012-01-01       Impact factor: 16.016

Review 5.  Programmed cell death in cerebral ischemia.

Authors:  S H Graham; J Chen
Journal:  J Cereb Blood Flow Metab       Date:  2001-02       Impact factor: 6.200

6.  An Efficient and Reliable Assay for Investigating the Effects of Hypoxia/Anoxia on Drosophila.

Authors:  Yiling Xia; Wangchao Xu; Shiquan Meng; Nastasia K H Lim; Wenan Wang; Fu-De Huang
Journal:  Neurosci Bull       Date:  2017-09-02       Impact factor: 5.203

7.  Gene expression patterns in mouse cortical penumbra after focal ischemic brain injury and reperfusion.

Authors:  Arezou S Sarabi; Hui Shen; Yun Wang; Barry J Hoffer; Cristina M Bäckman
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

Review 8.  Stroke.

Authors:  Geoffrey A Donnan; Marc Fisher; Malcolm Macleod; Stephen M Davis
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

Review 9.  Stroke in 2015: the year of endovascular treatment.

Authors:  Keith W Muir
Journal:  Lancet Neurol       Date:  2015-12-08       Impact factor: 44.182

10.  The 1027th target candidate in stroke: Will NADPH oxidase hold up?

Authors:  Kim A Radermacher; Kirstin Wingler; Pamela Kleikers; Sebastian Altenhöfer; Johannes Jr Hermans; Christoph Kleinschnitz; Harald Hhw Schmidt
Journal:  Exp Transl Stroke Med       Date:  2012-05-24
View more
  3 in total

1.  SARM1 participates in axonal degeneration and mitochondrial dysfunction in prion disease.

Authors:  Meng-Yu Lai; Jie Li; Xi-Xi Zhang; Wei Wu; Zhi-Ping Li; Zhi-Xin Sun; Meng-Yang Zhao; Dong-Ming Yang; Dong-Dong Wang; Wen Li; De-Ming Zhao; Xiang-Mei Zhou; Li-Feng Yang
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

2.  BMAL1 attenuates intracerebral hemorrhage-induced secondary brain injury in rats by regulating the Nrf2 signaling pathway.

Authors:  Yan Gong; Guoguo Zhang; Bing Li; Cheng Cao; Demao Cao; Xiang Li; Haiying Li; Ming Ye; Haitao Shen; Gang Chen
Journal:  Ann Transl Med       Date:  2021-11

Review 3.  Multifaceted roles of SARM1 in axon degeneration and signaling.

Authors:  Thomas J Waller; Catherine A Collins
Journal:  Front Cell Neurosci       Date:  2022-08-25       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.